The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
105090406 10509040 6 F 2014 20160324 20141009 20160331 EXP US-ASTRAZENECA-2014SE69488 ASTRAZENECA 65.00 YR F Y 51.70000 KG 20160331 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
105090406 10509040 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 320 MCG, TWO TIMES A DAY U 21929 BID
105090406 10509040 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 320 MCG, TWO TIMES A DAY U 21929 BID
105090406 10509040 3 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG, 2 PUFFS TWICE PER DAY U 21929 BID
105090406 10509040 4 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG, 2 PUFFS TWICE PER DAY U 21929 BID
105090406 10509040 5 SS TUDORZA PRESSAIR ACLIDINIUM BROMIDE 1 Respiratory (inhalation) U 0 400 UG INHALATION POWDER BID
105090406 10509040 6 SS TUDORZA PRESSAIR ACLIDINIUM BROMIDE 1 Respiratory (inhalation) U 0 400 UG INHALATION POWDER BID
105090406 10509040 7 C PREVACID LANSOPRAZOLE 1 Oral 0 30 MG BID
105090406 10509040 8 C PREVACID LANSOPRAZOLE 1 Oral 0 30 MG BID
105090406 10509040 9 C PREVACID LANSOPRAZOLE 1 Oral 0 30 MG QD
105090406 10509040 10 C PREVACID LANSOPRAZOLE 1 Oral 0 30 MG QD
105090406 10509040 11 C ZETIA EZETIMIBE 1 Oral 0 10 MG QD
105090406 10509040 12 C VERAPAMIL VERAPAMIL HYDROCHLORIDE 1 Oral 0 240 MG QD
105090406 10509040 13 C CLONAZEPAM. CLONAZEPAM 1 Oral 0 1 MG TID
105090406 10509040 14 C ADDARALL 2 Oral 0 15 MG QD
105090406 10509040 15 C SELENIUM SELENIUM 1 Oral 0
105090406 10509040 16 C FISH OIL FISH OIL 1 Oral 0
105090406 10509040 17 C OSCAL CALCIUM CARBONATE 1 Oral 0 500 MG
105090406 10509040 18 C ZOCOR SIMVASTATIN 1 0
105090406 10509040 19 C PROVENTIL ALBUTEROL 1 0
105090406 10509040 20 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral AS REQUIRED 0
105090406 10509040 21 C LANSOPRAZOLE. LANSOPRAZOLE 1 0
105090406 10509040 22 C AFRIN OXYMETAZOLINE 1 Nasal AS REQUIRED 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
105090406 10509040 1 Chronic obstructive pulmonary disease
105090406 10509040 2 Asthma
105090406 10509040 3 Chronic obstructive pulmonary disease
105090406 10509040 4 Asthma
105090406 10509040 5 Chronic obstructive pulmonary disease
105090406 10509040 6 Asthma
105090406 10509040 7 Ulcer
105090406 10509040 8 Gastrooesophageal reflux disease
105090406 10509040 9 Ulcer
105090406 10509040 10 Gastrooesophageal reflux disease
105090406 10509040 11 Blood cholesterol abnormal
105090406 10509040 12 Dizziness
105090406 10509040 13 Anxiety
105090406 10509040 14 Attention deficit/hyperactivity disorder
105090406 10509040 15 Liver disorder
105090406 10509040 17 Mineral supplementation
105090406 10509040 19 Unevaluable event
105090406 10509040 20 Drug hypersensitivity

Outcome of event

Event ID CASEID OUTC COD
105090406 10509040 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
105090406 10509040 Alveolar osteitis
105090406 10509040 Back injury
105090406 10509040 Candida infection
105090406 10509040 Cataract
105090406 10509040 Dysphonia
105090406 10509040 Dyspnoea
105090406 10509040 Fall
105090406 10509040 Fatigue
105090406 10509040 Gastrooesophageal reflux disease
105090406 10509040 Hot flush
105090406 10509040 Hypersomnia
105090406 10509040 Intentional device misuse
105090406 10509040 Intentional product misuse
105090406 10509040 Lymphadenopathy
105090406 10509040 Malaise
105090406 10509040 Muscle strain
105090406 10509040 Pain
105090406 10509040 Pain in extremity
105090406 10509040 Panic attack
105090406 10509040 Productive cough
105090406 10509040 Sinus disorder
105090406 10509040 Stress
105090406 10509040 Viral infection
105090406 10509040 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
105090406 10509040 1 2012 201410 0
105090406 10509040 2 2012 201410 0
105090406 10509040 11 2004 0
105090406 10509040 12 2007 0
105090406 10509040 13 2012 0
105090406 10509040 14 2013 0